Study guide

16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects

IJCAHPO Certified Ophthalmic Medical Technologist COMT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements

1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification

2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology

2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway

3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety

3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety

4 Chapter 4: Ophthalmic History Taking & Clinical Documentation

4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record

5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision

5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction

6 Chapter 6: Tonometry, Keratometry & Pupil Measurement

6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria

7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis

7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment

8 Chapter 8: Refraction, Retinoscopy & Refinement

8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations

9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics

9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations

10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy

10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training

11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation

11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing

12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique

12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics

13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols

13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials

14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)

14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics

15 Chapter 15: Fluorescein Angiography Principles & Technique

15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management

16 Chapter 16: Angiographic Interpretation & Pathology

16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology

17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography

17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers

18 Chapter 18: Ophthalmic Photography & Videography

18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management

19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)

19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging

20 Chapter 20: Biometry, Topography & Corneal Analysis

20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth

21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting

21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems

22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications

22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis

23 Chapter 23: Ocular Pharmacology

23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF

24 Chapter 24: Microbiology & Ocular Specimen Collection

24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection

25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery

25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs

26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery

26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol

27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures

27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)

28 Chapter 28: Ophthalmic Patient Services & Education

28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support

29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance

29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements

16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects

Key Takeaways Explain This Topic AI

Hypofluorescence arises from either vascular non-perfusion (absence of intravascular dye due to capillary dropout or vessel occlusion) or optical blocking defects (an opaque material obscuring underlying fluorescence).

The anatomical depth of an optical blocking material dictates which vascular beds are obscured: preretinal opacities block both retinal and choroidal vessels, intraretinal opacities block the choroid while allowing superficial retinal vessels to pass over, and subretinal opacities block only the choroidal flush.

In central retinal vein occlusion (CRVO), the presence of 10 or more disc areas of retinal capillary non-perfusion on fluorescein angiography defines an ischemic CRVO, conferring high risk for anterior segment neovascularization and neovascular glaucoma.

Cotton wool spots represent axoplasmic stasis in the nerve fiber layer from terminal arteriolar infarction; on angiography, they produce focal hypofluorescence via a combination of optical blockage and focal capillary non-perfusion.

Congenital hypertrophy of the retinal pigment epithelium (CHRPE) causes dense sub-neurosensory blocking of the choroidal flush with sharp, scalloped borders, frequently accompanied by peripheral hypopigmented lacunae that produce window defects.

Last updated: September 2026

Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects

Quick Summary: In fluorescein angiography, hypofluorescence represents an abnormal reduction or total absence of expected fluorescence. The differential diagnosis bifurcates into two fundamentally distinct mechanisms: vascular non-perfusion (true lack of intravascular dye due to vessel closure or capillary dropout) and optical blocking defects (normal underlying fluorescence masked by an intervening opaque material). Technologists determine the exact anatomical depth of pathology by evaluating which fluorescent vascular layers remain visible.

1. Pathophysiological Classification of Hypofluorescence

When reviewing an angiogram, any area that appears abnormally dark relative to surrounding normal tissue represents hypofluorescence. To reach an accurate diagnosis, the certified technologist must immediately ask two critical questions:

Is the dye failing to arrive (vascular non-perfusion or filling defect)?

Is the dye present beneath the surface, but obstructed from view by an optical barrier (blocking defect)?

Understanding this core distinction determines whether a patient requires urgent retinal vascular intervention, panretinal photocoagulation for ischemia, or systemic evaluation for thromboembolism or giant cell arteritis.

2. Vascular Non-Perfusion (Ischemic Filling Defects)

Vascular non-perfusion occurs when anatomic, mechanical, or inflammatory processes prevent fluorescein from entering the lumen of arterioles, capillaries, or venules.

Angiographic Hallmarks

Persistent Intravascular Darkness: Non-perfused areas remain dark across all phases of the study, from early arterial transit through late elimination frames.

"Pruned Tree" Vascular Morphology: Abrupt truncation of arterioles and capillaries, leaving ghost vessels or bare, unperfused retinal beds.

Hyperfluorescent Border Zones: The margins between perfused and non-perfused retina frequently demonstrate microaneurysms, telangiectatic collateral vessels, and active hyperfluorescent leakage driven by localized VEGF upregulation.

  • Retinal Capillary Non-Perfusion & Clinical Conditions
  • Diabetic Retinopathy & Diabetic Macular Ischemia (DMI)

Pericyte death, endothelial apoptosis, and capillary basement membrane thickening cause progressive capillary occlusion.

Foveal Avascular Zone (FAZ) Evaluation: The normal FAZ measures approximately 300 to 500 µm in diameter (roughly 0.3 to 0.5 disc diameters) and is circumscribed by a continuous, smooth capillary ring.

In DMI, capillary dropout breaks the ring, producing an enlarged (>600 µm), notched, highly irregular FAZ that correlates directly with irreversible visual acuity loss.

In the retinal periphery, widespread capillary non-perfusion triggers high VEGF expression, inducing preretinal neovascularization (NVE) at the interface of perfused and non-perfused retina.

Retinal Vein Occlusions (CRVO / BRVO)

Elevated venous intraluminal pressure, stasis, and thrombosis lead to extensive capillary bed destruction.

The Ischemic Threshold (CVOS Standard): The landmark Central Vein Occlusion Study (CVOS) established that the presence of 10 or more disc areas of retinal capillary non-perfusion on standard 7-field fluorescein angiography defines an ischemic CRVO .

Clinical Significance: Patients with ischemic CRVO have up to a 60% risk of developing anterior segment neovascularization (neovascularization of the iris [NVI / rubeosis iridis] and neovascularization of the anterior chamber angle [NVA]). This can precipitate acute, intractable neovascular glaucoma (NVG) , historically known as "90-day glaucoma." Detecting 10+ disc areas of non-perfusion mandates urgent clinical follow-up, undilated gonioscopy, and consideration of prompt anti-VEGF therapy or panretinal photocoagulation (PRP).

Retinal Artery Occlusion (CRAO / BRAO)

Embolic or thrombotic occlusion of the central retinal artery or its branches results in catastrophic cessation of retinal blood flow.

Angiographic Findings: Severe prolongation of the arm-to-retina circulation time (normally 10–15 seconds; delayed to >25–40 seconds). Retinal arteries show sluggish, segmented flow ("boxcarring" or rouleaux formation) and take tens of seconds to fill, while the underlying choroidal flush appears normal and on schedule.

Cilioretinal Artery Sparing: In approximately 15% to 20% of normal eyes , a cilioretinal artery arises from the posterior ciliary circulation rather than the central retinal artery. In a patient with CRAO who possesses a cilioretinal artery, angiography reveals a striking, isolated hyperfluorescent island of perfused papillomacular retina providing preserved central foveal vision against a completely non-perfused, dark peripheral retina.

Cotton Wool Spots (Axoplasmic Stasis vs. Capillary Non-Perfusion)

Cotton wool spots (nerve fiber layer infarcts) are caused by acute occlusion of terminal precapillary arterioles.

Dual Mechanism of Hypofluorescence: On angiography, a cotton wool spot produces hypofluorescence through both mechanisms simultaneously :

Optical Blocking: Swollen, opaque axoplasm filled with degenerated mitochondria and organelles (cytoid bodies) in the nerve fiber layer physically blocks the underlying choroidal flush.

Vascular Non-Perfusion: The terminal capillary plexus supplying that focal region is completely shut down.

In mid-to-late frames, dilated capillary loops or microaneurysms at the periphery of the cotton wool spot frequently demonstrate microvascular leakage.

3. Choroidal Non-Perfusion (Choriocapillaris Occlusion)

Because the choroidal circulation provides 85% of total ocular blood flow and nourishes the outer retina, choroidal non-perfusion leads to acute photoreceptor and RPE dysfunction.

Giant Cell Arteritis (GCA / Arteritic AION)

Granulomatous inflammation and thrombosis of the short posterior ciliary arteries (SPCAs) severely compromise choroidal lobular perfusion.

Angiographic Hallmark: Dramatic delay in choroidal filling , often exceeding 5 to 10 seconds beyond normal transit onset. While normal choroidal lobules fill homogeneously within 1–2 seconds of dye arrival, GCA demonstrates large, geographic, wedge-shaped or triangular zones of absent choroidal flush that remain hypofluorescent well into the arteriovenous phase.

Diagnostic Urgency: In an elderly patient (>50 years) presenting with acute visual loss and an ischemic optic neuropathy, identifying choroidal filling delay on FA is virtually diagnostic of arteritic AION and demands emergency systemic high-dose corticosteroid therapy to protect the contralateral eye from bilateral blindness.

Hypertensive Choroidopathy

Acute, malignant systemic hypertension causes fibrinoid necrosis of choroidal arterioles.

Elschnig Spots: Focal, non-perfused choriocapillaris lobules that appear hypofluorescent in early angiographic frames, followed by late hyperfluorescent staining/leakage as damaged RPE tight junctions allow dye penetration. Over time, these resolve into small pigmented scars with pale atrophic halos.

Siegrist Streaks: Linear, hyperpigmented chains oriented along sclerotic choroidal vessels, reflecting linear streaks of choroidal vascular necrosis.

4. Optical Blocking Defects (Masking / Transmission Hypofluorescence)

An optical blocking defect occurs when normal, fluorescent structures are shielded from view by an anterior, light-absorbing or light-scattering substance.

Note

The Golden Rule of Angiographic Localization: An opaque lesion blocks all fluorescent structures that lie posterior to it, while all fluorescent structures located anterior to it remain fully visible.

  • Systematic Anatomical Localization Hierarchy
  • 1. Preretinal / Vitreous Blocking

Location: Anterior to the internal limiting membrane, within the posterior hyaloid space or vitreous gel.

Angiographic Pattern: BOTH retinal vessels and the choroidal flush are completely blocked. Retinal arterioles and venules abruptly vanish at the margin of the lesion.

Classic Causes:

Subhyaloid / Preretinal Hemorrhage: Often presents as a boat-shaped hemorrhage with a flat superior fluid level (gravitational pooling between retina and detached posterior hyaloid). Completely blocks all underlying retinal vessels.

Dense Vitreous Hemorrhage: Diffuse, floating hypofluorescent clouds obscuring entire retinal quadrants.

Preretinal Fibrosis / Dense Epiretinal Membranes: Mild attenuation of retinal vessel detail.

2. Intraretinal Blocking

Location: Situated within the layers of the neurosensory retina.

Angiographic Pattern: The superficial retinal vessels pass over the lesion and are clearly visible , but the deep retinal capillary networks and underlying choroidal flush are obscured.

Classic Causes:

Flame-Shaped Hemorrhages: Located in the superficial nerve fiber layer (NFL); follow the horizontal striations of axons and block underlying deep capillaries.

Dot-and-Blot Hemorrhages: Confined to the inner nuclear and outer plexiform layers (INL/OPL); appear as crisp, compact, circular hypofluorescent spots that block background choroidal flush while overlying superficial arterioles and venules run across them uninterrupted.

Hard Exudates: Dense lipid and lipoprotein precipitates residing in the outer plexiform layer; cause localized optical blockage of the choroidal flush.

3. Subretinal Blocking

Location: Situated between the neurosensory retina (photoreceptors) and the RPE monolayer.

Angiographic Pattern: The entire retinal vascular tree (both superficial and deep capillary plexuses) is 100% visible and anatomically pristine. However, the background choroidal flush is completely blacked out.

Classic Causes:

Subretinal Hemorrhage: Dark, solid hypofluorescent shield masking the choroid; frequently seen surrounding active CNV membranes in nAMD or trauma.

Vitelliform Material: Dense lipofuscin/turbid accumulation in Best disease or adult-onset foveomacular vitelliform dystrophy, producing an intense round foveal blocking defect.

Subretinal Fibrin / Proteinaceous Exudate: Dense coagulated fluid in aggressive CSCR or exudative retinal detachments.

4. Sub-RPE & RPE Blocking

Location: Within the RPE cells or between the RPE basement membrane and Bruch's membrane.

Angiographic Pattern: Normal retinal vessels course unimpeded; choroidal flush is totally masked; lesion margins are extraordinarily sharp and crisp.

Classic Causes:

Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE): High intracellular melanin density produces an intense, jet-black hypofluorescent lesion with sharp, scalloped borders. Peripheral depigmented lacunae within the CHRPE permit choroidal fluorescence to shine through, creating focal transmission window defects within a field of dense blockage.

Choroidal Nevus: Increased melanocyte density in the anterior choroidal stroma absorbs blue/green light, producing well-circumscribed, static choroidal blockage with undisturbed overlying retinal circulation.

Sub-RPE Hemorrhage: Blood beneath the RPE produces a dark, sharply demarcated dome that masks the choriocapillaris.

5. Comparative Differential Diagnostic Matrix

Feature Vascular Non-Perfusion Preretinal Blocking Intraretinal Blocking Subretinal / RPE Blocking

Retinal Vessels Absent, occluded, or pruned Completely blocked (vanish at border) Superficial vessels visible ; deep plexuses blocked Entirely visible and patent coursing over lesion

Choroidal Flush Visible (shines normally beneath empty retinal bed) Completely blocked Blocked beneath lesion Completely blocked beneath lesion

Lesion Borders Pruned vessel terminations; irregular geographic boundaries Corresponds exactly to mobile fluid or hemorrhage boundaries Flame-shaped, feathered, or discrete punctate dots Crisp, smooth, scalloped, or circular borders

Late Phase Dynamics Borders remain dark; margin microaneurysms may leak Remains persistently dark; no expansion Remains dark; no expansion Remains dark (unless associated with active CNV)

Pathologic Substrate Capillary dropout, thrombosis, or arteriolar occlusion Vitreous or subhyaloid blood, dense membrane Hemorrhages in NFL/INL, hard exudates, cotton wool spots Subretinal blood, CHRPE, dense nevus, vitelliform material

6. Clinical Pearls & Diagnostic Pitfalls

Warning

CHRPE vs. Choroidal Melanoma: Technologists must never confuse CHRPE with a malignant choroidal melanoma. On angiography, CHRPE is flat and densely hypofluorescent (complete blockage) across all transit phases, punctuated only by occasional window defects in depigmented lacunae. In contrast, a choroidal melanoma is an elevated mass that exhibits "double circulation" (simultaneous visualization of retinal and intrinsic tumor vessels) with early mottled hyperfluorescence, progressive late leakage, and pinpoint hot spots.

Important

Confirming Vascular Non-Perfusion vs. Hemorrhagic Blockage: When evaluating a diabetic eye with extensive intraretinal hemorrhages, dark areas on FA may represent either blood blockage or capillary non-perfusion. Compare the color fundus photo directly with the angiogram: if the dark area matches visible red blood on the photo, it is blockage . If the dark area corresponds to pale, structurally intact retina devoid of blood, it is true ischemic non-perfusion .

Loading diagram... Diagnostic Localization of Hypofluorescence